Inhibition of phosphatidylcholine synthesis is associated with excitotoxic cell death in cerebellar granule cell

T Gasull1, N DeGregorio-Rocasolano, M Enguita

  • 1Neurobiology Unit, Institut d'Investigacions Biomèdiques de Barcelona, Consejo Superior de Investigaciones Científicas (IDIBAPS), Barcelona, Spain.

Amino Acids
|October 10, 2002
PubMed

Insights

Glucose deprivation and glutamate exposure increase cell death by inhibiting phosphatidylcholine synthesis. This sustained inhibition, particularly after combined treatment, suggests a link to excitotoxic neuronal death.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Cerebellar granule cells are vulnerable to excitotoxicity, especially under conditions of glucose deprivation.
  • Glutamate excitotoxicity is a significant factor in neuronal damage.

Purpose of the Study:

  • To investigate the role of phosphatidylcholine (PC) synthesis inhibition in excitotoxic cell death of cerebellar granule cells.
  • To determine if combined glucose deprivation and glutamate exposure impact PC synthesis.

Main Methods:

  • Cultures of cerebellar granule cells were subjected to glucose deprivation (GD) and/or glutamate (GLU) exposure.
  • Phosphatidylcholine synthesis was measured by monitoring the incorporation of radiolabeled choline.
  • Choline kinase activity was assessed by measuring the conversion of choline to phosphocholine.

Main Results:

  • Both GD and GLU alone inhibited PC synthesis, with GD showing a more pronounced effect.
  • Combined GLU and GD treatment resulted in significant and prolonged inhibition of PC synthesis.
  • The inhibition of PC synthesis was linked to reduced choline kinase activity, but the sustained effect of combined treatment suggested downstream inhibition.

Conclusions:

  • Excitotoxic cell death in cerebellar granule cells is associated with a sustained inhibition of phosphatidylcholine synthesis.
  • Combined glucose deprivation and glutamate exposure induce a prolonged suppression of PC synthesis, potentially via an enzymatic step beyond choline kinase.

Related Concept Videos

Synthesis of Phosphatidylcholine in the ER Membrane01:27

Synthesis of Phosphatidylcholine in the ER Membrane

The ER synthesizes lipids for building cell membranes and performing cellular functions such as energy storage and signaling. The lipid synthesis machinery embedded in the ER membrane primarily collects all reactants from the cytosol. Following synthesis, the secretory pathway and the ER contact sites distribute these lipids to other cellular organelles. Additionally, the energy-rich triacylglycerides are transported from the ER via lipid droplets.
The major components of all eukaryotic cell...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...